← Back to Screener
Sinovac Biotech, Ltd (SVA)
Price$0.00
Value ScoreA
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-1.60%
Price vs S&P 500 (4W)-2.08%
VGM Score62.87
Market Capitalization$639.90M
All Metrics
P/CF (Annual)6.15x
Book Value / Share (Quarterly)$93.27
P/TBV (Annual)0.07x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-4.27%
Cash Flow / Share (Quarterly)$-4.06
Price vs S&P 500 (YTD)0.29%
Gross Margin (TTM)92.09%
Net Profit Margin (TTM)-29.06%
EPS (TTM)$-1.25
10-Day Avg Trading Volume0.00M
EPS Excl Extra (TTM)$-1.25
Revenue Growth (5Y)14.28%
EPS (Annual)$-1.00
ROI (Annual)-1.11%
Gross Margin (Annual)59.51%
Net Profit Margin (5Y Avg)13.77%
Cash / Share (Quarterly)$106.13
Revenue Growth QoQ (YoY)-13.33%
ROA (Last FY)-0.73%
Revenue Growth TTM (YoY)2.19%
EBITD / Share (TTM)$-3.21
ROE (5Y Avg)24.19%
Operating Margin (TTM)-103.87%
Cash Flow / Share (Annual)$-0.42
P/B Ratio0.07x
P/B Ratio (Quarterly)0.07x
Net Income / Employee (Annual)$-32,900
EV / Revenue (TTM)-1.30x
Net Interest Coverage (TTM)1.00x
ROA (TTM)-0.94%
EV / EBITDA (TTM)-1.46x
EPS Incl Extra (Annual)$-1.00
Current Ratio (Annual)10.31x
Quick Ratio (Quarterly)11.22x
3-Month Avg Trading Volume0.00M
52-Week Price Return0.00%
Revenue / Employee (TTM)$141,300
Tangible BV / Share (Quarterly)$93.26
P/S Ratio (Annual)1.43x
Asset Turnover (Annual)0.03x
52-Week High$6.47
Operating Margin (5Y Avg)-0.96%
EPS Excl Extra (Annual)$-1.00
CapEx CAGR (5Y)89.26%
Tangible BV CAGR (5Y)136.90%
26-Week Price Return0.00%
Quick Ratio (Annual)10.17x
13-Week Price Return0.00%
Total Debt / Equity (Annual)0.03x
Current Ratio (Quarterly)11.39x
Enterprise Value$-10.95B
Revenue / Share Growth (5Y)4.93%
Asset Turnover (TTM)0.03x
Book Value / Share Growth (5Y)112.74%
Revenue / Employee (Annual)$147,600
Inventory Turnover (Annual)1.13x
Pretax Margin (Annual)-34.14%
Cash / Share (Annual)$112.64
3-Month Return Std Dev0.00%
Gross Margin (5Y Avg)76.36%
Net Income / Employee (TTM)$-41,100
ROE (Last FY)-1.15%
EPS Basic Excl Extra (Annual)$-1.00
P/FCF (TTM)7.01x
Receivables Turnover (TTM)1.08x
Total Debt / Equity (Quarterly)0.04x
EPS Incl Extra (TTM)$-1.25
Receivables Turnover (Annual)0.97x
ROI (TTM)-1.39%
P/S Ratio (TTM)1.49x
Pretax Margin (5Y Avg)25.90%
Revenue / Share (Annual)$4.50
Tangible BV / Share (Annual)$93.26
Price vs S&P 500 (52W)-36.95%
Year-to-Date Return0.00%
5-Day Price Return0.00%
EPS Normalized (Annual)$-1.00
ROA (5Y Avg)13.28%
Net Profit Margin (Annual)-22.29%
Month-to-Date Return0.00%
Cash Flow / Share (TTM)$-5.38
EBITD / Share (Annual)$-4.64
Operating Margin (Annual)-134.52%
LT Debt / Equity (Annual)0.02x
ROI (5Y Avg)23.84%
LT Debt / Equity (Quarterly)0.02x
EPS Basic Excl Extra (TTM)$-1.25
P/TBV (Quarterly)0.07x
P/B Ratio (Annual)0.07x
Inventory Turnover (TTM)0.20x
Pretax Margin (TTM)-36.03%
Book Value / Share (Annual)$93.27
Price vs S&P 500 (13W)1.72%
Beta0.00x
P/FCF (Annual)0.04x
Revenue / Share (TTM)$4.31
ROE (TTM)-1.44%
52-Week Low$6.47
vGradeA
gGradeC
mGradeC
vgmGradeB
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SVASinovac Biotech, Ltd | A | C | C | $0.00 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Sinovac Biotech is a China-based biopharmaceutical company developing and commercializing vaccines for major infectious diseases. The company's portfolio includes vaccines for hepatitis A and B, hand-foot-mouth disease (EV71), influenza, coronavirus, pneumococcal disease, poliomyelitis, varicella, and mumps.